Details of the Drug Reposition

General Information of This Drug (ID: DMRWLB2)

• Drug Name: Fluticasone propionate (DMRWLB2)
• Synonyms: FLUTICASONE PROPIONATE; Flovent; Cutivate; Flixotide; Flonase; Flixonase; Flovent HFA; Flunase; Flutide; Fluspiral; Flusonal; atemur; Flutivate; Fluinol; Axotide; Asmatil; Brethal; Flovent Diskus 50; Flixotide Disks; Flixotide Disk; Flovent Diskus; Flovent Diskus 100; Flovent Diskus 250; Flixotide Inhaler; Trialona; Rinosone; Inalacor; Cultivate; Ubizol; Zoflut; Flixonase Nasal Spray; Flonase Aq; Fluticasonpropionat Allen; Fluticasone (propionate); UNII-O2GMZ0LF5W; CCI-18781; CCI 18781; MFCD00866007; O2GMZ0LF5W

Information on Drug Reposition of This Drug

8 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Primary cutaneous T-cell lymphoma	DIS35WVW	N.A.	Approved	[1]
Intrinsic asthma	DIS2U1Q9	N.A.	Approved	[1]
Granuloma annulare	DISMOUMI	N.A.	Approved	[1]
Exanthem	DISAFOQN	N.A.	Approved	[1]
Bronchiolitis	DISEE9BG	N.A.	Approved	[1]
Allergic rhinitis	DIS3U9HN	CA08.0	Approved	[1]
Pulmonary emphysema	DIS5M7HZ	CA21.Z	Approved	[1]
Allergic asthma	DISHF0H3	CA23.0	Approved	[1]

3 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Atopic dermatitis	DISTCP41	EA80	Discontinued in Phase 3	[2]
Seborrhoeic dermatitis	DISNWVJU	EA81	Discontinued in Phase 3	[3]
Contact dermatitis	DISQ3AU0	EK0Z	Discontinued in Phase 3	[4]

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic obstructive pulmonary disease	DISQCIRF	CA22	Discontinued in Phase 2	[5]

References

• [1] Fluticasone propionate FDA Label
• [2] Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
• [3] Prevention of Post-traumatic Seizures With Levetiracetam
• [4] Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage
• [5] Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients